Covid-19 roundup: Novavax recruits AstraZeneca vet as its new CMO — right after David Mott jumps on the board; Operation Warp Speed will cut to 7 candidates
One of the dark-horse contenders in a race to the finish line with a new vaccine for Covid-19 has just wooed a senior AstraZeneca researcher to the fold as its new chief medical officer.
Novavax reports that it has recruited Filip Dubovsky to the team after a 14-year stretch at MedImmune/AstraZeneca. While at the big AstraZeneca sub, Dubovsky had been area head for infectious diseases and vaccines. Earlier he had been scientific director for PATH, a malaria vaccine initiative.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.